Walgreens taps former McDonald’s CEO to be nonexecutive chairman
DEERFIELD, Ill. — Walgreens on Thursday named James Skinner, Walgreens board member since 2005 and recently retired McDonald’s CEO, as the new nonexecutive chairman of the board of Walgreens. Skinner will succeed Al McNally, who has served on the Walgreens board since 1999 and as nonexecutive chairman since 2009. McNally will continue serving on the Walgreens board.
“Al McNally’s extraordinary leadership as our board’s first lead director and first nonexecutive chairman of the board was instrumental and indispensable as Walgreens advanced its transformation … to become America’s most trusted and convenient provider of consumer goods and services, and pharmacy, health and wellness solutions," stated Bill Foote, Walgreens board director and chairman of the nominating and governance committee. "We are grateful that Walgreens will continue to benefit from Al’s leadership and vision on the board,” he said. “As Walgreens moves forward with its strategy to become a U.S. and world leader in pharmacy-led health and wellbeing, Jim Skinner’s long experience on the Walgreens board, and decades of global success with McDonald’s in expanding to Europe and emerging markets, make him an exceptional choice to lead our board into the future on behalf of shareholders and stakeholders.”
As McDonald’s CEO, Skinner led the world’s largest food service company with more than 33,000 restaurants in 119 countries. He served as McDonald’s CEO beginning in November 2004, and prior to that in a variety of other leadership positions for the company, both U.S. and globally. In addition to Walgreens, Skinner serves on the board of directors of Illinois Tool Works, Inc. He retired as McDonald’s CEO earlier this year.
“Jim Skinner’s long and successful record in retail and customer experience, both across the nation and around the world, will be enormously helpful at a time when Walgreens is launching with Alliance Boots the first global pharmacy-led health and wellbeing enterprise,” noted Greg Wasson, Walgreens president and CEO.
McNally served as the Walgreens board’s first lead director, beginning in January 2008. He subsequently served as chairman and acting CEO, and as nonexecutive chairman since 2009. He previously served as CEO of Harris Bank from 1993 to 2002 and chairman of the board of Harris Financial Corp. from 1998 to 2006.
Cardinal RBC lineup includes healthcare analyst, NCPA and significant CE opportunities
ORLANDO, Fla. — Cardinal Health on Thursday kicked off its Retail Business Conference, the company’s annual trade show for independent pharmacies catering to more than 7,000 attendees.
“RBC is an outstanding opportunity for independent pharmacy owners to network with thousands of their peers from across the country; tap into more continuing education courses than they’ll find anywhere else; and enjoy top-notch fun and entertainment with their families,” Cardinal Health SVP independent sales Steve Lawrence said. “RBC is also a great way for independent pharmacies to learn about the many ways Cardinal Health can help improve the efficiency and profitability of their businesses — so they can spend more time meeting and exceeding the needs of their patients.”
The event features an 83,000-sq.-ft. trade show floor, highlighting buying opportunities with more than 320 exhibitors. At the event, pharmacists again can access one of the industry’s largest and most complete lineups of continuing education opportunities, with nearly 50 courses on topics that can help them improve both their clinical and business operations. Pharmacists can also access seven full- or half-day continuing pharmacy education courses, on issues ranging from pharmacy-based immunization delivery to helping patients manage cardiovascular risk.
Keynote presentations will be made by both Myrtle Potter, CEO of the healthcare consulting firm Myrtle Potter and Co., and National Community Pharmacists Association CEO Douglas Hoey.
Potter formerly served in executive leadership positions at Merck, was president of Bristol-Myers Squibb and most recently COO and later president of Genentech. At this year’s RBC, Potter will share her candid assessment of the state of U.S. health care, the implications of the recent Supreme Court decision on healthcare reform and what it all means to independent pharmacy.
Hoey, who has spent more than 20 years working in and advocating for community pharmacies, is a licensed pharmacist in Oklahoma, Virginia and Texas and serves as a board member of the Pharmacy Compounding Accreditation Board, Surescripts, Mirixa, and the Pharmacy e-Health Information Technology Collaborative. He also has helped lead the NCPA team that scored legislative victories requiring prompt pay of Medicare Part D claims, winning a court injunction to delay average manufacturer price that saved community pharmacies more than $2 billion. He also has played an instrumental role in expanding NCPA membership by 20% over the past two years. Hoey will talk with RBC 2012 attendees about key issues facing community pharmacies, including the need for pharmacists to work together to affect legislative change that ensures patients have access to community pharmacy services. Hoey also will discuss the important role that improving patient medication adherence plays in the evolution of the community pharmacy business model; and about the role that revenue diversification plays in enhancing the long-term livelihood of community pharmacies.
Mermelada, Pomagria enter market
BALTIMORE — Two new ready-to-drink beverages have come to market.
Mermelada, a sweet red blend from Spain, is made from tempranillo, cabernet sauvignon and merlot grapes ripened to perfection and harvested at the peak of sweetness. Pomagria, the first pomegranate-flavored sangria, is unique blend of fresh pomegranate juice, red wine and oranges that delivers refreshing nuances of strawberry and apple that lend a slight tartness to its finish. Both beverages are distributed exclusively by Aveniu Brands.
Mermelada and Pomagria now are available for a suggested retail price of $11.99 each.